IDEAYA Biosciences Inc banner

IDEAYA Biosciences Inc
F:30J

Watchlist Manager
IDEAYA Biosciences Inc Logo
IDEAYA Biosciences Inc
F:30J
Watchlist
Price: 32.38 EUR 3.75% Market Closed
Market Cap: €2.7B

Wall St Price Targets

30J Price Targets Summary
IDEAYA Biosciences Inc

Wall Street analysts forecast 30J stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 30J is 37.59 EUR with a low forecast of 25.69 EUR and a high forecast of 46.91 EUR.

Lowest Forecast
Price Target
25.69 EUR
21% Downside
Average Forecast
Price Target
37.59 EUR
16% Upside
Highest Forecast
Price Target
46.91 EUR
45% Upside
IDEAYA Biosciences Inc Competitors:
Price Targets
APA
APA Corp (US)
-5% Downside

Revenue
Forecast

N/A
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat
N/A
Past Growth
37% / Year
Estimated Growth
Estimates Accuracy
2%
Average Beat

The compound annual growth rate for Revenue over the next 8 years is 37%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
1%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 30J's stock price target?
Price Target
37.59 EUR

According to Wall Street analysts, the average 1-year price target for 30J is 37.59 EUR with a low forecast of 25.69 EUR and a high forecast of 46.91 EUR.

What is the Revenue forecast for IDEAYA Biosciences Inc?
Projected CAGR
37%

The compound annual growth rate for Revenue over the next 8 years is 37%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett